Ongoing clinical trials are evaluating a new immunotherapeutic approach for the treatment of malignant melanoma–the combination of an oncolytic virus with checkpoint inhibition.
Sigrid Eckardt, PhD
Articles by Sigrid Eckardt, PhD
Latest Updated Articles
Combining Oncolytic Immunotherapy With Checkpoint Inhibitors Could Affect CurePublished: November 21st 2014 | Updated: